Catalyst Pharmaceutical
CPRX
CPRX
257 hedge funds and large institutions have $1.52B invested in Catalyst Pharmaceutical in 2022 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 97 increasing their positions, 79 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
257
Holders Change
+28
Holders Change %
+12.23%
% of All Funds
4.15%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.1%
New
52
Increased
97
Reduced
79
Closed
22
Calls
$6.89M
Puts
$1.98M
Net Calls
+$4.91M
Net Calls Change
+$4.33M
Top Buyers
Top Sellers
| 1 |
1
LSV Asset Management
Chicago,
Illinois
|
$18.9M |
| 2 |
2
Renaissance Technologies
New York
|
$22.9M |
| 3 |
3
Acadian Asset Management
Boston,
Massachusetts
|
$560K |
| 4 |
4
Prudential Financial
Newark,
New Jersey
|
$15.2M |
| 5 |
5
Norges Bank
Oslo,
Norway
|
$5.85M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
276
Bank of Nova Scotia
Toronto,
Ontario, Canada
| – | -$196K | -15,248 | Closed |
|
277
Verition Fund Management
Greenwich,
Connecticut
| – | -$129K | -10,022 | Closed |
|
|
ACM
278
Aquatic Capital Management
Chicago,
Illinois
| – | -$4K | -300 | Closed |
|